Analyst Recommendations

241.13 6.37(2.71%)09/13/2024
Madrigal Pharmaceuticals Inc (MDGL)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy9
Outperform6
Market Outperform4
Neutral2
Overweight2
Sell2

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades